Navigation Links
Artemis Diagnostics awarded two grants from Technology Strategy Board to develop cancer imaging technology
Date:12/7/2012

HERTFORDSHIRE, United Kingdom, Dec. 7, 2012 /PRNewswire-iReach/ -- Artemis Diagnostics, a developer of innovative imaging technologies for cancer surgery, announced today that the company has been awarded two Smart grants from the Technology Strategy Board, the UK's innovation agency. The two grants, totaling more than £120,000 (US$ 193,000), provide funding for the company to develop its imaging devices for clinical trials and to undertake market research in the US and UK.

Dr David Tuch, CEO of Artemis Diagnostics, commented, "We are pleased the Technology Strategy Board has selected Artemis Diagnostics to receive funding for our product development and market research. The Smart scheme is highly competitive and these awards provide further affirmation of the company's technology and the tremendous need for improved tools to detect cancer during surgery. We believe our molecular imaging technology will provide a significant advance in precision-guided surgery. We look forward to working with our surgeon collaborators to bring our technology into clinical trials."

About the Technology Strategy Board
The Technology Strategy Board is the UK's innovation agency.  Its goal is to accelerate economic growth by stimulating and supporting business-led innovation.  Sponsored by the Department for Business, Innovation and Skills (BIS), the Technology Strategy Board brings together business, research and the public sector, supporting and accelerating the development of innovative products and services to meet market needs, tackle major societal challenges and help build the future economy. For more information please visit www.innovateuk.org.

About the Smart scheme
Managed by the Technology Strategy Board, the Smart scheme offers funding to small and medium-sized enterprises (SMEs) to engage in R&D projects in the strategically important areas of science, engineering and technology, from which successful new products, processes and services could emerge. http://www.innovateuk.org/deliveringinnovation/smart.ashx

About Artemis Diagnostics
Artemis Diagnostics is a medical device start-up seeking to improve health outcomes for cancer patients through image-guided surgery. The company's molecular imaging technology, based on Cerenkov luminescence imaging, has the potential to detect cancer in real-time during surgery, providing more accurate cancer treatment while sparing healthy tissue. For more information contact info@artemisdiagnostics.com or visit www.artemisdiagnostics.com.

Media Contact: Artemis Diagnostics Artemis Diagnostics, +44 7725 832 539, info@artemisdiagnostics.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Artemis Diagnostics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Market for Molecular Diagnostics to Exceed $10.7 Billion by 2018, Regenerative Medicine to Top $4.4 Billion
2. High Degree of Disease Prevalence Sustains Diabetes Diagnostics Market in Europe, Finds Frost & Sullivan
3. Merrimack Pharmaceuticals To Present Phase I Data On MM-302 And Preclinical Data On Companion Diagnostics Both For The Treatment Of HER2-Positive Breast Cancer
4. Cynosure to Present at Canaccord Genuity Medical Technology & Diagnostics Forum
5. Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes
6. Roche Diagnostics Breaks Ground on New Learning and Development Center
7. Mayor Greg Ballard to Join Roche Diagnostics Leaders at Groundbreaking of New Learning and Development Center
8. Quest Diagnostics Confirms Investor Day on November 16
9. Johnson & Johnson Postpones Medical Devices & Diagnostics Review
10. Johnson & Johnson to Host Medical Devices & Diagnostics Review
11. Life Technologies to Partner with Bristol-Myers Squibb for Companion Diagnostics Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/14/2017)... HACKENSACK, N.J. and PETACH TIKVAH, ... Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult ... for the second quarter ending June 30, 2017. ... advanced stages of preparing for our pivotal Phase 3 ... Chaim Lebovits , President and Chief Executive Officer ...
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 million ... continuing operations Second-quarter 2017 ... million Second-quarter 2017 Sterile ... Second-quarter 2017 adjusted diluted earnings ... to $0.93 Second-quarter 2017 ...
(Date:8/7/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s largest independent specialty ... 2017.  All comparisons, unless otherwise noted, are to the quarter ... Second Quarter 2017 Highlights include: ... of 3.5% Total prescriptions dispensed of 220,000, ... versus 7.6% Gross profit per prescription ...
Breaking Medicine Technology:
(Date:8/22/2017)... SAN FRANCISCO BAY AREA, CA (PRWEB) , ... ... ... to premier, Nuvesse, an accessible luxurious collection of unique masks and serums that ... latest in scientific skin care advancements, at the 2017 Indie Beauty Expo on ...
(Date:8/22/2017)... ... August 22, 2017 , ... ... to good health is as simple as eating healthy foods. But this well-known ... storing fat, making insulin, or breaking apart carbohydrates—depends not only on properties of ...
(Date:8/22/2017)... ... August 22, 2017 , ... Pivot Point ... of Zack Tisch as the firm’s new Consulting Services Executive. Mr. Tisch will ... national accounts, from assisting clients with initial vendor selection and pre-implementation planning through ...
(Date:8/22/2017)... , ... August 22, 2017 , ... ... (RCM) solutions, announced recently the availability of a new professional fee E/M leveling ... for their service to the healthcare industry. E/M coding is complex which supports ...
(Date:8/22/2017)... , ... August 22, 2017 , ... Five Star Glass is new to the Texas ... and replacement of auto glass for most makes and models, in Grand Prairie, TX, located ... , They have been a family owned business for the past 40 years with ...
Breaking Medicine News(10 mins):